Home Equities Score AIM ImmunoTech Inc. (AIM) Stock Undergoes Minor Volatility After Announcing Extension of...

AIM ImmunoTech Inc. (AIM) Stock Undergoes Minor Volatility After Announcing Extension of Collaboration with Smoore

AIM ImmunoTech Inc. (AIM) stock prices were down by 1.42% as of the market closing on May 28th, 2021, bringing the price per share down to USD$2.08 at the end of the trading day. Subsequent pre-market fluctuations have seen the stock fall by 2.40%, bringing it down to USD$2.03.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Extension of Agreement with Smoore

May 27th, 2021 saw the company announce the extension of its Material Transfer and Research Agreement with Shenzhen Smoore Technology Ltd by two years. The collaboration with the subsidiary of Smoore International Holdings Ltd aims to develop Ampligen as a potential inhalation therapy for Covid-19 and other respiratory viral diseases. The agreement was entered into by AIM on April 1st, 2020, with the aim of studying the utilization of a new Smoore inhalation delivery device and Ampligen as a prospective treatment approach for the coronavirus pandemic.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Read More

Ampligen Development

Concurrently, the past year has seen the company focus on the development of a personal inhalation device designed to administer Ampligen, given temperature parameters of dsRNA. More recently, AIM has used an ex vivo 3D model in primary human respiratory epithelial cells at Utah State University to study the safety and efficacy of Ampligen. The study showed Ampligen as being able to lower Covid-19 infectious viral yields by 90% at clinically viable intranasal Ampligen dosage levels. Having conducted relevant intranasal safety testing, AIM forecasts commencing inhalation safety testing before the end of 2021.

Scope of Ampligen

On account of the readiness for the development of the concept or an Ampligen inhalation delivery device and the company’s track record of high safety and efficacy, AIM is pushing for the further development and commercialization of Ampligen. With the world hurtling towards global immunizations, the company hopes to address a portion of that market and for Ampligen to also treat other respiratory viral diseases that will have a scope beyond the pandemic. The company is currently in the process of planning a Phase 1/1 inhalation clinical study that will operate in tandem with Smoore’s device development testing.

Partnership Merits

One of the Smoore’s focal points for research and development is the application of vaping technology in healthcare and pharmaceutical fields. Their collaboration with AIM will explore applications of advanced atomization technology in relation to medical inhalation therapy. Smoore will coordinate its device development efforts in conjunction with AIM’s plan and the regulation needs to move into next phase testing on schedule.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Future Outlook for AIM

With the extension of the collaboration with Smoore, AIM has consolidated a potentially prosperous several quarter ahead of it. The company is poised to capitalize on the joint efforts of the parties involved to facilitate further growth. Current and potential investors are hopeful that the company will manage to leverage the resources at their disposal to usher in significant and sustained increases in shareholder value.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Onesmart International Education Group Ltd. (ONE) stock surges during current market. What’s driving it high?

Onesmart International Education Group Ltd. (NASDAQ: ONE) stock gains by 111.86% in the current market trading session. OneSmart International Education is a major Chinese...

LivePerson Inc. (LPSN) stock plunge during pre-market. What’s driving it low?

LivePerson Inc. (NASDAQ: LPSN) stock gained by 0.86% at last close whereas the LPSN stock declines by 9.39% in the pre-market trading session. Through...

The Clorox Company Ltd. (CLX) stock decline during pre-market. Here’s the recent update

The Clorox Company Ltd. (NASDAQ: CLX) stock gained by 0.17% at last close whereas the CLX stock price fell by 11.59% in the pre-market....

IT Tech Packaging Inc. (ITP) stock gains during pre-market. Here’s what’s happening?

IT Tech Packaging Inc. (NASDAQ: ITP) stock gained by 7.53% at last close while the ITP stock price rises by 2.04% in the pre-market...

Why did The9 Limited (NCTY) stock turnaround in the after-hours on Friday?

The9 Limited (NCTY) shares gained 6.87% in after-hours on Friday, July 30, 2021, and closed the weekly trading at $11.98 per share. in the...

OneConnect Financial Technology Inc. (OCFT) stock plunge during current market. Here’s what you should know.

OneConnect Financial Technology Inc. (NASDAQ: OCFT) stock declines by 22.12% in the current market trading. In China, OneConnect is the most popular technology-as-a-service platform...

Invitae Corporation Inc. (NVTA) stock surge during current market. Here’s the update:

Invitae Corporation Inc. (NASDAQ: NVTA) stock gains by 12.35% in the current market trading session. Invitae Corporation is a prominent medical genetics business whose...

LivePerson Inc. (LPSN) stock plunge during pre-market. What’s driving it low?

LivePerson Inc. (NASDAQ: LPSN) stock gained by 0.86% at last close whereas the LPSN stock declines by 9.39% in the pre-market trading session. Through...

Related News

OneConnect Financial Technology Inc. (OCFT) stock plunge during current market. Here’s what you should know.

OneConnect Financial Technology Inc. (NASDAQ: OCFT) stock declines by 22.12% in the current market trading. In China, OneConnect is the most popular technology-as-a-service platform...

Invitae Corporation Inc. (NVTA) stock surge during current market. Here’s the update:

Invitae Corporation Inc. (NASDAQ: NVTA) stock gains by 12.35% in the current market trading session. Invitae Corporation is a prominent medical genetics business whose...

Alto Ingredients Inc. (ALTO) stock fall during pre-market trading. Here’s what you should know?

Alto Ingredients Inc. (NASDAQ: ALTO) stock gained by 5.99% at last close whereas the ALTO stock-price plunge by 9.89% in the pre-market trading session....

Cuentas Inc. (CUEN) stock rises during after-hour trading, given no current update.

Cuentas Inc. (NASDAQ: CUEN) stock declined by 4.68% at last close whereas the CUEN stock price gains by 2.6% in the after-market. Cuentas is...

Why did Applied DNA Sciences Inc. (APDN) stock face headwinds in the after-hours on Tuesday?

Applied DNA Sciences Inc. (APDN) shares lost 3.82% in after-hours on Tuesday, August 03, 2021, and closed the daily trading at $6.55 per share....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam